Provided by Tiger Trade Technology Pte. Ltd.

TherapeuticsMD

2.22
+0.15007.25%
Volume:117.05K
Turnover:260.93K
Market Cap:25.70M
PE:-118.41
High:2.30
Open:2.20
Low:2.17
Close:2.07
52wk High:2.95
52wk Low:0.9900
Shares:11.57M
Float Shares:9.49M
Volume Ratio:25.50
T/O Rate:1.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0187
EPS(LYR):-0.0527
ROE:-1.08%
ROA:-2.88%
PB:0.95
PE(LYR):-42.09

Loading ...

Mar 26, 2020

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
Mar 24, 2020

Major Issues Report

Current report, items 5.02, 7.01, and 9.01
Mar 03, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Feb 24, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 20, 2020

Major Issues Report

Current report, items 2.02, 2.03, 7.01, and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 06, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 21, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 14, 2020

Major Issues Report

Current report, items 2.02, 7.01, and 9.01
Dec 30, 2019

Major Issues Report

Current report, items 1.01, 7.01, and 9.01
Dec 18, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Dec 10, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 19, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Nov 08, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 06, 2019

Major Issues Report

Current report, items 2.02, 7.01, and 9.01
Oct 29, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Oct 24, 2019

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
Oct 23, 2019

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses